A Double blind, randomized, placebo controlled clinical trial to evaluate safety and efficacy of GP/AYU/2021/001 Kit in patients with SARS-CoV-2 Infection. - NA

Mr Kamlesh Thummar0 个研究点目标入组 300 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Patients with RT-PCR confirmed COVID-19 illness
•Mild to Moderately Covid 19 disease (NEWS score less than or equal to 8)
•Signed informed consent must be obtained and documented according to national/local regulations

•Pregnant women.
•Breastfeeding women.
•Requiring ICU admission at screening
•Patients above 65 years of age and below 18 Years
•Past History of MI, Epileptic episodes
•Any other co-morbidity (uncontrolled diabetes, severe hypertension from subject history) which
•is at the critical stage at a screening
•Any other condition by which subject proves unfit from the investigator perspective
•Not giving consent.

发起方

Mr Kamlesh Thummar